Score Breakdown
Offering Ability
46
Cash Runway
85
Float Risk
52
Warrant Exposure
90
Convertible Debt
35
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 60%
🔄 Reverse Split
model est. 70%
• 50-day avg $0.21 below $1 exchange minimum
• Only 6 months cash — financial pressure
📜 Warrant Exercise
model 60%
• Massive warrant overhang: 37% of shares outstanding
• Warrant risk score very high (90/100)
💰 Capital Raise
model 35%
• Low cash runway: 6 months remaining
Market Data
Market Cap$22.11M
Shares Outstanding96.54M
Float40.10M
Cash$731.0K
Debt$2.79M
Short InterestN/A
Institutional Holdings
Institutional data not yet available.
Short Interest
Short Interest1.4K
Days to Cover1.0
% of FloatN/A
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2026-06-30
xbrl
XBRL CONVERTIBLE
2025-12-31
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual GTHP Dilution Snapshot
Guided Therapeutics, Inc. (GTHP) has a DilutionScore of 64/100, rated High dilution risk. Score date: August 28, 2026.
- Stored outstanding warrants: 35.9M.
- Recent SEC activity tracked for GTHP: xbrl on 2026-06-30; xbrl on 2025-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles: